Implementation of colorectal cancer screening in Finland: Experiences from the first three years of a public health programme

Zeitschrift fur Gastroenterologie

Volumn 46, Issue SUPPL. 1, 2008, Pages

  Malila, Nea ^a   Oivanen, T ^b   Hakama, M ^a  

^a FINNISH CANCER REGISTRY   (Finland)

^b Pirkanmaa Cancer Society   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CLINICAL TRIAL; COHORT ANALYSIS; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FINLAND; HEALTH PROGRAM; HEALTH SERVICE; HEMATOCHEZIA; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE;

ADENOMA; AGE FACTORS; AGED; COLONIC POLYPS; COLONOSCOPY; COLORECTAL NEOPLASMS; FINLAND; HEALTH PLAN IMPLEMENTATION; HUMANS; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEX FACTORS; SURVIVAL ANALYSIS;

EID: 42249104907     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-963490     Document Type: Conference Paper

References (16)

1. Finnish Cancer Registry. Cancer in Finland 2002 and 2003. Helsinki: Cancer Society of Finland, 2005
2. Kronborg O, Fenger C, Olsen J et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996; 348: 1467-1471
3. Hardcastle JD, Chamberlain JO, Robinson MH et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996; 348: 1472-1477
4. Mandel JS, Bond JH, Church TR et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993; 328: 1365-1371
5. Bretthauer M, Gondal G, Larsen K et al. Design, organization and management of a controlled population screening study for detection of colorectal neoplasia: attendance rates in the NORCCAP study (Norwegian Colorectal Cancer Prevention). Scand J Gastroenterol 2002; 37: 568-573
6. Atkin WS, Edwards R, Wardle J et al. Design of a multicentre randomised trial to evaluate flexible sigmoidoscopy in colorectal cancer screening. J Med Screen 2001; 8: 137-144
7. Segnan N, Senore C, Andreoni B et al. Baseline findings of the Italian multicenter randomized controlled trial of "once-only sigmoidoscopy" - SCORE. J Natl Cancer Inst 2002; 94: 1763-1772
8. Council Recommendation of 2 December 2003 on cancer screening. Official Journal of the European Union 2003; 2003/878/EC: 34-38
9. Hakama M, Hoff G, Kronborg O et al. Screening for colorectal cancer. Acta Oncol 2005; 44: 425-439
10. Malila N, Hakama M, Pukkala E. A 25-year follow-up of a population screened with faecal occult blood test in Finland. Acta Oncol 2007; In press
11. Malila N, Anttila A, Hakama M. Colorectal cancer screening in Finland: details of the national screening programme implemented in Autumn 2004. J Med Screen 2005; 12: 28-32
12. Towler BP, Irwig L, Glasziou P et al. Screening for colorectal cancer using the faecal occult blood test, hemoccult. Cochrane Database Syst Rev 2000; CD001216
13. Mandel JS, Church TR, Ederer F et al. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst 1999; 91: 434-437
14. Steele RJ, Parker R, Patnick J et al. A demonstration pilot trial for colorectal cancer screening in the United Kingdom: a new concept in the introduction of healthcare strategies. J Med Screen 2001; 8: 197-202
15. Weller D, Alexander FE, Orbell S et al. Evaluation of the UK Colorectal Cancer Screening Pilot. Edinburgh: University of Edinburgh, 2003
16. Hakama M, Pukkala E, Heikkila M et al. Effectiveness of the public health policy for breast cancer screening in Finland: population based cohort study. BMJ 1997; 314: 864-867